speb/financial-data huggingface dataset:
NYR.BR income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -4500842.97
NYR.BR income_statement (annual, 2024-12-31) — Total Other Finance Cost: -457886.53
NYR.BR income_statement (annual, 2024-12-31) — Total Unusual Items: 499895.97
NYR.BR income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 499895.97
NYR.BR balance_sheet (annual, 2024-12-31) — Working Capital: 2312989.87
NYR.BR balance_sheet (quarterly, 2024-12-31) — Working Capital: 2312989.87
NYR.BR balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 254731.73
NYR.BR balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 1216395875.47
NYR.BR balance_sheet (quarterly, 2025-06-30) — Capital Stock: 114134760.97
NYR.BR balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 1218637.01
NYR.BR balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 11218637.01
NYR.BR balance_sheet (quarterly, 2025-06-30) — Cash Financial: 1218637.01
NYR.BR balance_sheet (quarterly, 2025-06-30) — Common Stock: 114134760.97
NYR.BR balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: -8755744.97
NYR.BR balance_sheet (quarterly, 2025-06-30) — Current Assets: 11506777.21
NYR.BR balance_sheet (quarterly, 2025-06-30) — Current Debt: 10615743.87
NYR.BR balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 10615743.87
NYR.BR balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 11089944.82
NYR.BR balance_sheet (quarterly, 2025-06-30) — Invested Capital: 1859998.90
NYR.BR balance_sheet (quarterly, 2025-06-30) — Long Term Provisions: 9172577.36
NYR.BR balance_sheet (quarterly, 2025-06-30) — Net Debt: 9397106.86
NYR.BR balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -8755744.97
NYR.BR balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 109873001.00
NYR.BR balance_sheet (quarterly, 2025-06-30) — Other Receivables: 288140.20
NYR.BR balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 10000000.00
NYR.BR balance_sheet (quarterly, 2025-06-30) — Payables: 270657.94
NYR.BR balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -1355543409.47
NYR.BR balance_sheet (quarterly, 2025-06-30) — Share Issued: 109873001.00
NYR.BR balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: -8755744.97
NYR.BR balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -8755744.97
NYR.BR balance_sheet (quarterly, 2025-06-30) — Total Assets: 11506777.21
NYR.BR balance_sheet (quarterly, 2025-06-30) — Total Capitalization: -8755744.97
NYR.BR balance_sheet (quarterly, 2025-06-30) — Total Debt: 10615743.87
NYR.BR balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: -8755744.97
NYR.BR balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 20262522.18
NYR.BR balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 0.00
NYR.BR balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 9172577.36
NYR.BR balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 15926.21
NYR.BR balance_sheet (quarterly, 2025-06-30) — Working Capital: 416832.39
NYR.BR income_statement (annual, 2025-12-31) — +Operating Expense: 37260.66
NYR.BR income_statement (annual, 2025-12-31) — +Total Revenue: 0.00
NYR.BR balance_sheet (annual, 2025-12-31) — Accounts Payable: 579084.08
NYR.BR balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 579084.08
NYR.BR balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 1216395875.47
NYR.BR balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 1216395875.47
NYR.BR balance_sheet (annual, 2025-12-31) — Capital Stock: 114134760.97
NYR.BR balance_sheet (quarterly, 2025-12-31) — Capital Stock: 114134760.97
NYR.BR balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 858303.16
NYR.BR balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 858303.16
NYR.BR balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 9858303.16
NYR.BR balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 9858303.16
NYR.BR balance_sheet (annual, 2025-12-31) — Cash Financial: 858303.16
NYR.BR balance_sheet (quarterly, 2025-12-31) — Cash Financial: 858303.16
NYR.BR balance_sheet (annual, 2025-12-31) — Common Stock: 114134760.97
NYR.BR balance_sheet (quarterly, 2025-12-31) — Common Stock: 114134760.97
NYR.BR balance_sheet (annual, 2025-12-31) — Common Stock Equity: -11387959.83
NYR.BR balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: -11387959.83
NYR.BR income_statement (annual, 2025-12-31) — Cost Of Revenue: 4372402.88
NYR.BR balance_sheet (annual, 2025-12-31) — Current Assets: 10627296.54
NYR.BR balance_sheet (quarterly, 2025-12-31) — Current Assets: 10627296.54
NYR.BR balance_sheet (annual, 2025-12-31) — Current Debt: 10832406.40
NYR.BR balance_sheet (quarterly, 2025-12-31) — Current Debt: 10832406.40
NYR.BR balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 10832406.40
NYR.BR balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 10832406.40
NYR.BR balance_sheet (annual, 2025-12-31) — Current Liabilities: 11563671.53
NYR.BR balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 11563671.53
NYR.BR income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -2955982.02
NYR.BR income_statement (annual, 2025-12-31) — EBIT: -2670851.29
NYR.BR income_statement (annual, 2025-12-31) — EBITDA: -2670851.29
NYR.BR income_statement (annual, 2025-12-31) — Gross Profit: -4372402.88
NYR.BR income_statement (annual, 2025-12-31) — Interest Expense: 285130.73
NYR.BR income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 285130.73
NYR.BR balance_sheet (annual, 2025-12-31) — Invested Capital: -555553.43
NYR.BR balance_sheet (quarterly, 2025-12-31) — Invested Capital: -555553.43
NYR.BR balance_sheet (annual, 2025-12-31) — Long Term Provisions: 10451584.84
NYR.BR balance_sheet (quarterly, 2025-12-31) — Long Term Provisions: 10451584.84
NYR.BR balance_sheet (annual, 2025-12-31) — Net Debt: 9974103.24
NYR.BR balance_sheet (quarterly, 2025-12-31) — Net Debt: 9974103.24
NYR.BR income_statement (annual, 2025-12-31) — Net Income: -2955982.02
NYR.BR income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -2955982.02
NYR.BR income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -2955982.02
NYR.BR income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -2955982.02
NYR.BR income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -2955982.02
NYR.BR income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -2955982.02
NYR.BR income_statement (annual, 2025-12-31) — Net Interest Income: -85304.14
NYR.BR income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -85304.14
NYR.BR balance_sheet (annual, 2025-12-31) — Net Tangible Assets: -11387959.83
NYR.BR balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -11387959.83
NYR.BR income_statement (annual, 2025-12-31) — Normalized EBITDA: -4209836.95
NYR.BR income_statement (annual, 2025-12-31) — Normalized Income: -4494967.68
NYR.BR income_statement (annual, 2025-12-31) — Operating Income: -4409663.54
NYR.BR income_statement (annual, 2025-12-31) — Operating Revenue: 0.00
NYR.BR balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 109873001.00
NYR.BR balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 109873001.00
NYR.BR income_statement (annual, 2025-12-31) — Other Operating Expenses: 76635.63
NYR.BR balance_sheet (annual, 2025-12-31) — Other Receivables: 768993.38
NYR.BR balance_sheet (quarterly, 2025-12-31) — Other Receivables: 768993.38
NYR.BR balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 9000000.00
NYR.BR balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 9000000.00
NYR.BR income_statement (annual, 2025-12-31) — Other Special Charges: -1538985.66
NYR.BR income_statement (annual, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
NYR.BR balance_sheet (annual, 2025-12-31) — Payables: 579084.08
NYR.BR balance_sheet (quarterly, 2025-12-31) — Payables: 579084.08
NYR.BR income_statement (annual, 2025-12-31) — Pretax Income: -2955982.02
NYR.BR income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 4372402.88
NYR.BR balance_sheet (annual, 2025-12-31) — Retained Earnings: -1358175624.33
NYR.BR balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -1358175624.33
NYR.BR balance_sheet (annual, 2025-12-31) — Share Issued: 109873001.00
NYR.BR balance_sheet (quarterly, 2025-12-31) — Share Issued: 109873001.00
NYR.BR income_statement (annual, 2025-12-31) — Special Income Charges: 1538985.66
NYR.BR balance_sheet (annual, 2025-12-31) — Stockholders Equity: -11387959.83
NYR.BR balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: -11387959.83
NYR.BR balance_sheet (annual, 2025-12-31) — Tangible Book Value: -11387959.83
NYR.BR balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -11387959.83
NYR.BR income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
NYR.BR income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.00
NYR.BR balance_sheet (annual, 2025-12-31) — Total Assets: 10627296.54
NYR.BR balance_sheet (quarterly, 2025-12-31) — Total Assets: 10627296.54
NYR.BR balance_sheet (annual, 2025-12-31) — Total Capitalization: -11387959.83
NYR.BR balance_sheet (quarterly, 2025-12-31) — Total Capitalization: -11387959.83
NYR.BR balance_sheet (annual, 2025-12-31) — Total Debt: 10832406.40
NYR.BR balance_sheet (quarterly, 2025-12-31) — Total Debt: 10832406.40
NYR.BR balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: -11387959.83
NYR.BR balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: -11387959.83
NYR.BR income_statement (annual, 2025-12-31) — Total Expenses: 4409663.54
NYR.BR balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 22015256.37
NYR.BR balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 22015256.37
NYR.BR balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 0.00
NYR.BR balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 0.00
NYR.BR balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 10451584.84
NYR.BR balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 10451584.84
NYR.BR income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -2870677.88
NYR.BR income_statement (annual, 2025-12-31) — Total Other Finance Cost: -199826.59
NYR.BR income_statement (annual, 2025-12-31) — Total Unusual Items: 1538985.66
NYR.BR income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 1538985.66
NYR.BR balance_sheet (annual, 2025-12-31) — Working Capital: -936374.99
NYR.BR balance_sheet (quarterly, 2025-12-31) — Working Capital: -936374.99
NYT cash_flow (annual, 2021-12-31) — Common Stock Issuance: 2454000.00
NYT cash_flow (annual, 2021-12-31) — Deferred Income Tax: -6358000.00
NYT cash_flow (annual, 2021-12-31) — Deferred Tax: -6358000.00
NYT income_statement (annual, 2021-12-31) — Earnings From Equity Interest: 0.00
NYT cash_flow (annual, 2021-12-31) — Gain Loss On Investment Securities: -27156000.00
NYT cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of Business: 0.00
NYT cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of PPE: 0.00
NYT income_statement (annual, 2021-12-31) — Gain On Sale Of Ppe: 0.00
NYT income_statement (annual, 2021-12-31) — Gain On Sale Of Security: 27156000.00
NYT cash_flow (annual, 2021-12-31) — Issuance Of Capital Stock: 2454000.00
NYT cash_flow (annual, 2021-12-31) — Long Term Debt Payments: 0.00
NYT cash_flow (annual, 2021-12-31) — Net Business Purchase And Sale: 0.00
NYT cash_flow (annual, 2021-12-31) — Net Issuance Payments Of Debt: 0.00
NYT cash_flow (annual, 2021-12-31) — Net Long Term Debt Issuance: 0.00
NYT income_statement (annual, 2021-12-31) — Other Special Charges: 3831000.00
NYT cash_flow (annual, 2021-12-31) — Purchase Of Business: 0.00
NYT cash_flow (annual, 2021-12-31) — Repayment Of Debt: 0.00
NYT income_statement (annual, 2021-12-31) — Restructuring And Mergern Acquisition: 0.00
NYT income_statement (annual, 2022-12-31) — +Operating Expense: 843651000.00
NYT income_statement (annual, 2022-12-31) — +Total Revenue: 2308321000.00
NYT balance_sheet (annual, 2022-12-31) — Accounts Payable: 114646000.00
NYT balance_sheet (annual, 2022-12-31) — Accounts Receivable: 217533000.00
NYT balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -823024000.00
NYT balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 255515000.00
NYT balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -12260000.00
NYT cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 4069000.00
NYT balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 138917000.00
NYT income_statement (annual, 2022-12-31) — Basic Average Shares: 166871000.00
NYT income_statement (annual, 2022-12-31) — Basic EPS: 1.04
NYT cash_flow (annual, 2022-12-31) — Beginning Cash Position: 334306000.00
NYT balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 730119000.00
NYT cash_flow (annual, 2022-12-31) — Capital Expenditure: -36961000.00
NYT cash_flow (annual, 2022-12-31) — Capital Expenditure Reported: -36961000.00
NYT balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 59124000.00
NYT balance_sheet (annual, 2022-12-31) — Capital Stock: 17707000.00
NYT balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 221385000.00
NYT balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 347357000.00
NYT cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -56790000.00
NYT cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -174306000.00
NYT cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -73561000.00
NYT cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 150687000.00
NYT cash_flow (annual, 2022-12-31) — Change In Account Payable: -111216000.00
NYT cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -23220000.00
NYT cash_flow (annual, 2022-12-31) — Change In Other Working Capital: 2844000.00
NYT cash_flow (annual, 2022-12-31) — Change In Payable: -111216000.00
NYT cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: -111216000.00
NYT cash_flow (annual, 2022-12-31) — Change In Receivables: 20889000.00
NYT cash_flow (annual, 2022-12-31) — Change In Working Capital: -110703000.00
NYT cash_flow (annual, 2022-12-31) — Changes In Account Receivables: 20889000.00
NYT cash_flow (annual, 2022-12-31) — Changes In Cash: -97180000.00
NYT balance_sheet (annual, 2022-12-31) — Common Stock: 17707000.00
NYT cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -56790000.00
NYT balance_sheet (annual, 2022-12-31) — Common Stock Equity: 1597967000.00
NYT cash_flow (annual, 2022-12-31) — Common Stock Issuance: 3000.00
NYT cash_flow (annual, 2022-12-31) — Common Stock Payments: -105056000.00
NYT balance_sheet (annual, 2022-12-31) — Construction In Progress: 24192000.00
NYT income_statement (annual, 2022-12-31) — Cost Of Revenue: 1208933000.00
NYT balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 300619000.00
NYT balance_sheet (annual, 2022-12-31) — Current Assets: 655675000.00
NYT balance_sheet (annual, 2022-12-31) — Current Liabilities: 571210000.00
NYT balance_sheet (annual, 2022-12-31) — Defined Pension Benefit: 69521000.00
NYT cash_flow (annual, 2022-12-31) — Depreciation: 92577000.00
NYT cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 92577000.00
NYT income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 82654000.00
NYT cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 92577000.00
NYT income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 82654000.00
NYT income_statement (annual, 2022-12-31) — Diluted Average Shares: 167141000.00
NYT income_statement (annual, 2022-12-31) — Diluted EPS: 1.04
NYT income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 173905000.00
NYT income_statement (annual, 2022-12-31) — EBIT: 236799000.00
NYT income_statement (annual, 2022-12-31) — EBITDA: 329376000.00
NYT income_statement (annual, 2022-12-31) — Earnings From Equity Interest: 0.00
NYT cash_flow (annual, 2022-12-31) — Earnings Losses From Equity Investments: 0.00
NYT cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -1953000.00
NYT balance_sheet (annual, 2022-12-31) — Employee Benefits: 251755000.00
NYT cash_flow (annual, 2022-12-31) — End Cash Position: 235173000.00
NYT cash_flow (annual, 2022-12-31) — Financing Cash Flow: -174306000.00
NYT balance_sheet (annual, 2022-12-31) — Foreign Currency Translation Adjustments: -510000.00
NYT cash_flow (annual, 2022-12-31) — Free Cash Flow: 113726000.00
NYT cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of Business: 0.00
NYT cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: -34227000.00
NYT income_statement (annual, 2022-12-31) — Gain On Sale Of Business: 0.00
NYT income_statement (annual, 2022-12-31) — Gain On Sale Of Ppe: 34227000.00
NYT balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -357847000.00
NYT income_statement (annual, 2022-12-31) — General And Administrative Expense: 289259000.00
NYT balance_sheet (annual, 2022-12-31) — Goodwill: 414046000.00
NYT balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 726380000.00
NYT balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 229793000.00
NYT balance_sheet (annual, 2022-12-31) — Gross PPE: 1434322000.00
NYT income_statement (annual, 2022-12-31) — Gross Profit: 1099388000.00
NYT cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 110161000.00
NYT income_statement (annual, 2022-12-31) — Interest Expense: 800000.00
NYT income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 800000.00
NYT income_statement (annual, 2022-12-31) — Interest Income: 7264000.00
NYT income_statement (annual, 2022-12-31) — Interest Income Non Operating: 7264000.00
NYT cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 1583000.00
NYT balance_sheet (annual, 2022-12-31) — Invested Capital: 1597967000.00
NYT cash_flow (annual, 2022-12-31) — Investing Cash Flow: -73561000.00
NYT balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 138917000.00
NYT balance_sheet (annual, 2022-12-31) — Investments And Advances: 138917000.00
NYT cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 3000.00
NYT balance_sheet (annual, 2022-12-31) — Land And Improvements: 106275000.00
NYT balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 59124000.00
NYT balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 59124000.00
NYT balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 74196000.00
NYT balance_sheet (annual, 2022-12-31) — Minimum Pension Liabilities: -348947000.00
NYT balance_sheet (annual, 2022-12-31) — Minority Interest: 2005000.00
NYT income_statement (annual, 2022-12-31) — Minority Interests: 0.00
NYT cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -515586000.00
NYT cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -105053000.00
NYT income_statement (annual, 2022-12-31) — Net Income: 173905000.00
NYT income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 173905000.00
NYT income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 173905000.00
NYT income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 173905000.00
NYT income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 173905000.00
NYT cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 173905000.00
NYT income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 173905000.00
NYT income_statement (annual, 2022-12-31) — Net Interest Income: 6464000.00
NYT cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 476504000.00
NYT income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: 6464000.00
NYT cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -12463000.00
NYT cash_flow (annual, 2022-12-31) — Net Other Investing Changes: 2482000.00
NYT balance_sheet (annual, 2022-12-31) — Net PPE: 611298000.00
NYT balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 871587000.00
NYT balance_sheet (annual, 2022-12-31) — Non Current Deferred Assets: 96363000.00
NYT balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 14635000.00
NYT balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 96363000.00
NYT balance_sheet (annual, 2022-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 251755000.00
NYT income_statement (annual, 2022-12-31) — Normalized EBITDA: 333930000.00
NYT income_statement (annual, 2022-12-31) — Normalized Income: 177260791.21
NYT cash_flow (annual, 2022-12-31) — Operating Cash Flow: 150687000.00
NYT cash_flow (annual, 2022-12-31) — Operating Gains Losses: -48287000.00
NYT income_statement (annual, 2022-12-31) — Operating Income: 255737000.00
NYT income_statement (annual, 2022-12-31) — Operating Revenue: 2075650000.00
NYT balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 165064455.00
NYT balance_sheet (annual, 2022-12-31) — Other Current Assets: 35926000.00
NYT balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 155945000.00
NYT income_statement (annual, 2022-12-31) — Other Gand A: 289259000.00
NYT income_statement (annual, 2022-12-31) — Other Income Expense: -26202000.00
NYT balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 312334000.00
NYT cash_flow (annual, 2022-12-31) — Other Non Cash Items: 3820000.00
NYT balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 230618000.00
NYT balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 37056000.00
NYT income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: -21648000.00
NYT balance_sheet (annual, 2022-12-31) — Other Properties: 499540000.00
NYT balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 125972000.00
NYT balance_sheet (annual, 2022-12-31) — Payables: 114646000.00
NYT balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 415265000.00
NYT cash_flow (annual, 2022-12-31) — Pension And Employee Benefit Expense: -14060000.00
NYT balance_sheet (annual, 2022-12-31) — Prepaid Assets: 54859000.00
NYT income_statement (annual, 2022-12-31) — Pretax Income: 235999000.00
NYT balance_sheet (annual, 2022-12-31) — Properties: 0.00
NYT cash_flow (annual, 2022-12-31) — Purchase Of Business: -515586000.00
NYT cash_flow (annual, 2022-12-31) — Purchase Of Investment: -8480000.00
NYT balance_sheet (annual, 2022-12-31) — Receivables: 217533000.00
NYT income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 1199010000.00
NYT income_statement (annual, 2022-12-31) — Reconciled Depreciation: 92577000.00
NYT cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -105056000.00
NYT income_statement (annual, 2022-12-31) — Research And Development: 204185000.00
NYT income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: 34712000.00
NYT balance_sheet (annual, 2022-12-31) — Retained Earnings: 1958859000.00
NYT cash_flow (annual, 2022-12-31) — Sale Of Investment: 484984000.00
NYT income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 267553000.00
NYT income_statement (annual, 2022-12-31) — Selling General And Administration: 556812000.00
NYT balance_sheet (annual, 2022-12-31) — Share Issued: 177069320.00
NYT income_statement (annual, 2022-12-31) — Special Income Charges: -4554000.00
NYT cash_flow (annual, 2022-12-31) — Stock Based Compensation: 35306000.00
NYT balance_sheet (annual, 2022-12-31) — Stockholders Equity: 1597967000.00
NYT balance_sheet (annual, 2022-12-31) — Tangible Book Value: 871587000.00
NYT income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -1198208.79
NYT income_statement (annual, 2022-12-31) — Tax Provision: 62094000.00
NYT income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.26
NYT balance_sheet (annual, 2022-12-31) — Total Assets: 2533752000.00
NYT balance_sheet (annual, 2022-12-31) — Total Capitalization: 1597967000.00
NYT balance_sheet (annual, 2022-12-31) — Total Debt: 59124000.00
NYT balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 1599972000.00
NYT income_statement (annual, 2022-12-31) — Total Expenses: 2052584000.00
NYT balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 933780000.00
NYT balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 1873097000.00
NYT balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 362570000.00
NYT income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 201967000.00
NYT income_statement (annual, 2022-12-31) — Total Unusual Items: -4554000.00
NYT income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -4554000.00
NYT balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 12004865.00
NYT balance_sheet (annual, 2022-12-31) — Treasury Stock: 276267000.00
NYT balance_sheet (annual, 2022-12-31) — Unrealized Gain Loss: -8390000.00
NYT balance_sheet (annual, 2022-12-31) — Working Capital: 84465000.00
NYT income_statement (annual, 2022-12-31) — Write Off: 4069000.00
NYT income_statement (annual, 2023-12-31) — +Operating Expense: 886185000.00
NYT income_statement (annual, 2023-12-31) — +Total Revenue: 2426152000.00
NYT balance_sheet (annual, 2023-12-31) — Accounts Payable: 116942000.00
NYT balance_sheet (annual, 2023-12-31) — Accounts Receivable: 242488000.00
NYT balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -870329000.00
NYT balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 301287000.00
NYT balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -12800000.00
NYT cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 15239000.00
NYT balance_sheet (annual, 2023-12-31) — Available For Sale Securities: 257633000.00
NYT income_statement (annual, 2023-12-31) — Basic Average Shares: 164721000.00
NYT income_statement (annual, 2023-12-31) — Basic EPS: 1.41
NYT cash_flow (annual, 2023-12-31) — Beginning Cash Position: 235173000.00
NYT balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 729559000.00
NYT cash_flow (annual, 2023-12-31) — Capital Expenditure: -22669000.00
NYT cash_flow (annual, 2023-12-31) — Capital Expenditure Reported: -22669000.00
NYT balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 42905000.00
NYT balance_sheet (annual, 2023-12-31) — Capital Stock: 17775000.00
NYT balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 289472000.00
NYT balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 451566000.00
NYT cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -69464000.00
NYT cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -132710000.00
NYT cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -159690000.00
NYT cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 360618000.00
NYT cash_flow (annual, 2023-12-31) — Change In Account Payable: -7321000.00
NYT cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -2154000.00
NYT cash_flow (annual, 2023-12-31) — Change In Other Working Capital: 27260000.00
NYT cash_flow (annual, 2023-12-31) — Change In Payable: -7321000.00
NYT cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -7321000.00
NYT cash_flow (annual, 2023-12-31) — Change In Receivables: -24955000.00
NYT cash_flow (annual, 2023-12-31) — Change In Working Capital: -7170000.00
NYT cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -24955000.00
NYT cash_flow (annual, 2023-12-31) — Changes In Cash: 68218000.00
NYT balance_sheet (annual, 2023-12-31) — Common Stock: 17775000.00
NYT cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -69464000.00
NYT balance_sheet (annual, 2023-12-31) — Common Stock Equity: 1763219000.00
NYT cash_flow (annual, 2023-12-31) — Common Stock Issuance: 0.00
NYT cash_flow (annual, 2023-12-31) — Common Stock Payments: -44553000.00
NYT balance_sheet (annual, 2023-12-31) — Construction In Progress: 20333000.00
NYT income_statement (annual, 2023-12-31) — Cost Of Revenue: 1249061000.00
NYT balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 321845000.00
NYT balance_sheet (annual, 2023-12-31) — Current Assets: 781653000.00
NYT balance_sheet (annual, 2023-12-31) — Current Liabilities: 611559000.00
NYT balance_sheet (annual, 2023-12-31) — Defined Pension Benefit: 83016000.00
NYT cash_flow (annual, 2023-12-31) — Depreciation: 95347000.00
NYT cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 95347000.00
NYT income_statement (annual, 2023-12-31) — Depreciation Amortization Depletion Income Statement: 86115000.00
NYT cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 95347000.00
NYT income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 86115000.00
NYT income_statement (annual, 2023-12-31) — Diluted Average Shares: 165663000.00
NYT income_statement (annual, 2023-12-31) — Diluted EPS: 1.40
NYT income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 232387000.00
NYT income_statement (annual, 2023-12-31) — EBIT: 303602000.00
NYT income_statement (annual, 2023-12-31) — EBITDA: 398949000.00
NYT cash_flow (annual, 2023-12-31) — Earnings Losses From Equity Investments: -2477000.00
NYT cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: -219000.00
NYT balance_sheet (annual, 2023-12-31) — Employee Benefits: 238853000.00
NYT cash_flow (annual, 2023-12-31) — End Cash Position: 303172000.00
NYT cash_flow (annual, 2023-12-31) — Financing Cash Flow: -132710000.00
NYT balance_sheet (annual, 2023-12-31) — Foreign Currency Translation Adjustments: 910000.00
NYT cash_flow (annual, 2023-12-31) — Free Cash Flow: 337949000.00
NYT cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of Business: -2477000.00
NYT cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: 0.00
NYT income_statement (annual, 2023-12-31) — Gain On Sale Of Business: 2477000.00
NYT income_statement (annual, 2023-12-31) — Gain On Sale Of Ppe: 0.00
NYT balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -352862000.00
NYT income_statement (annual, 2023-12-31) — General And Administrative Expense: 311039000.00
NYT balance_sheet (annual, 2023-12-31) — Goodwill: 416098000.00
NYT balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 699111000.00
NYT balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 255288000.00
NYT balance_sheet (annual, 2023-12-31) — Gross PPE: 1419948000.00
NYT income_statement (annual, 2023-12-31) — Gross Profit: 1177091000.00
NYT cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 71814000.00
NYT income_statement (annual, 2023-12-31) — Interest Expense: 1014000.00
NYT income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 1014000.00
NYT income_statement (annual, 2023-12-31) — Interest Income: 22116000.00
NYT income_statement (annual, 2023-12-31) — Interest Income Non Operating: 22116000.00
NYT cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 708000.00
NYT balance_sheet (annual, 2023-12-31) — Invested Capital: 1763219000.00
NYT cash_flow (annual, 2023-12-31) — Investing Cash Flow: -159690000.00
NYT balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 257633000.00
NYT balance_sheet (annual, 2023-12-31) — Investments And Advances: 257633000.00
NYT cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 0.00
NYT balance_sheet (annual, 2023-12-31) — Land And Improvements: 106648000.00
NYT balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 42905000.00
NYT balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 42905000.00
NYT balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 80710000.00
NYT balance_sheet (annual, 2023-12-31) — Minimum Pension Liabilities: -353286000.00
NYT balance_sheet (annual, 2023-12-31) — Minority Interest: 0.00
NYT income_statement (annual, 2023-12-31) — Minority Interests: -365000.00
NYT cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: 0.00
NYT cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -44553000.00
NYT income_statement (annual, 2023-12-31) — Net Income: 232387000.00
NYT income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 232387000.00
NYT income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 232752000.00
NYT income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 232387000.00
NYT income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 232387000.00
NYT cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 232752000.00
NYT income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 232752000.00
NYT income_statement (annual, 2023-12-31) — Net Interest Income: 21102000.00
NYT cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -141775000.00
NYT income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 21102000.00
NYT cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -18693000.00
NYT cash_flow (annual, 2023-12-31) — Net Other Investing Changes: 4754000.00
NYT balance_sheet (annual, 2023-12-31) — Net PPE: 549619000.00
NYT balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 1064108000.00
NYT balance_sheet (annual, 2023-12-31) — Non Current Deferred Assets: 114505000.00
NYT balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 13752000.00
NYT balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 114505000.00
NYT balance_sheet (annual, 2023-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 238853000.00
NYT income_statement (annual, 2023-12-31) — Normalized EBITDA: 411711000.00
NYT income_statement (annual, 2023-12-31) — Normalized Income: 242188216.00
NYT cash_flow (annual, 2023-12-31) — Operating Cash Flow: 360618000.00
NYT cash_flow (annual, 2023-12-31) — Operating Gains Losses: -32610000.00
NYT income_statement (annual, 2023-12-31) — Operating Income: 290906000.00
NYT income_statement (annual, 2023-12-31) — Operating Revenue: 2161359000.00
NYT balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 164541961.00
NYT balance_sheet (annual, 2023-12-31) — Other Current Assets: 27887000.00
NYT balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 172772000.00
NYT income_statement (annual, 2023-12-31) — Other Gand A: 311039000.00
NYT income_statement (annual, 2023-12-31) — Other Income Expense: -9420000.00
NYT balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 283013000.00
NYT cash_flow (annual, 2023-12-31) — Other Non Cash Items: 2284000.00
NYT balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 226581000.00
NYT balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 44307000.00
NYT income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 3342000.00
NYT balance_sheet (annual, 2023-12-31) — Other Properties: 482698000.00
NYT balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 162094000.00
NYT balance_sheet (annual, 2023-12-31) — Payables: 116942000.00
NYT balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 438787000.00
NYT cash_flow (annual, 2023-12-31) — Pension And Employee Benefit Expense: -30133000.00
NYT balance_sheet (annual, 2023-12-31) — Prepaid Assets: 59712000.00
NYT income_statement (annual, 2023-12-31) — Pretax Income: 302588000.00
NYT balance_sheet (annual, 2023-12-31) — Properties: 0.00
NYT cash_flow (annual, 2023-12-31) — Purchase Of Business: 0.00
NYT cash_flow (annual, 2023-12-31) — Purchase Of Investment: -286448000.00
NYT balance_sheet (annual, 2023-12-31) — Receivables: 242488000.00
NYT income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 1239829000.00
NYT income_statement (annual, 2023-12-31) — Reconciled Depreciation: 95347000.00
NYT cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -44553000.00
NYT income_statement (annual, 2023-12-31) — Research And Development: 228804000.00
NYT income_statement (annual, 2023-12-31) — Restructuring And Mergern Acquisition: 0.00
NYT balance_sheet (annual, 2023-12-31) — Retained Earnings: 2117839000.00
NYT cash_flow (annual, 2023-12-31) — Sale Of Investment: 144673000.00
NYT income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 260227000.00
NYT income_statement (annual, 2023-12-31) — Selling General And Administration: 571266000.00
NYT balance_sheet (annual, 2023-12-31) — Share Issued: 177731886.00
NYT income_statement (annual, 2023-12-31) — Special Income Charges: -12762000.00
NYT cash_flow (annual, 2023-12-31) — Stock Based Compensation: 54776000.00
NYT balance_sheet (annual, 2023-12-31) — Stockholders Equity: 1763219000.00
NYT balance_sheet (annual, 2023-12-31) — Tangible Book Value: 1064108000.00
NYT income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -2960784.00
NYT income_statement (annual, 2023-12-31) — Tax Provision: 69836000.00
NYT income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.23
NYT balance_sheet (annual, 2023-12-31) — Total Assets: 2714595000.00
NYT balance_sheet (annual, 2023-12-31) — Total Capitalization: 1763219000.00
NYT balance_sheet (annual, 2023-12-31) — Total Debt: 42905000.00
NYT balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 1763219000.00
NYT income_statement (annual, 2023-12-31) — Total Expenses: 2135246000.00
NYT balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 951376000.00
NYT balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 1930465000.00
NYT balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 339817000.00
NYT income_statement (annual, 2023-12-31) — Total Operating Income As Reported: 276272000.00
NYT income_statement (annual, 2023-12-31) — Total Unusual Items: -12762000.00
NYT income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -12762000.00
NYT balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 13189925.00
NYT balance_sheet (annual, 2023-12-31) — Treasury Stock: 320820000.00
NYT balance_sheet (annual, 2023-12-31) — Unrealized Gain Loss: -486000.00
NYT balance_sheet (annual, 2023-12-31) — Working Capital: 170094000.00
NYT income_statement (annual, 2023-12-31) — Write Off: 15239000.00
NYT cash_flow (quarterly, 2024-09-30) — Asset Impairment Charge: 0.00
NYT balance_sheet (quarterly, 2024-09-30) — Current Deferred Liabilities: 177215000.00
NYT balance_sheet (quarterly, 2024-09-30) — Current Deferred Revenue: 177215000.00
NYT income_statement (quarterly, 2024-09-30) — Impairment Of Capital Assets: 0.00
NYT balance_sheet (quarterly, 2024-09-30) — Minority Interest: 0.00
NYT income_statement (quarterly, 2024-09-30) — Salaries And Wages: 0.00
NYT income_statement (annual, 2024-12-31) — +Operating Expense: 917489000.00
NYT income_statement (annual, 2024-12-31) — +Total Revenue: 2585919000.00
NYT balance_sheet (annual, 2024-12-31) — Accounts Payable: 123606000.00
NYT balance_sheet (annual, 2024-12-31) — Accounts Receivable: 249530000.00
NYT balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -905512000.00
NYT balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 356450000.00
NYT balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -12118000.00
NYT cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 0.00
NYT cash_flow (quarterly, 2024-12-31) — Asset Impairment Charge: 0.00
NYT balance_sheet (annual, 2024-12-31) — Available For Sale Securities: 345946000.00
NYT income_statement (annual, 2024-12-31) — Basic Average Shares: 164425000.00
NYT income_statement (annual, 2024-12-31) — Basic EPS: 1.79
NYT cash_flow (annual, 2024-12-31) — Beginning Cash Position: 303172000.00
NYT balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 736608000.00
NYT balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 736608000.00
NYT cash_flow (annual, 2024-12-31) — Capital Expenditure: -29173000.00
NYT cash_flow (annual, 2024-12-31) — Capital Expenditure Reported: -29173000.00
NYT balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 37255000.00
NYT balance_sheet (quarterly, 2024-12-31) — Capital Lease Obligations: 37255000.00
NYT balance_sheet (annual, 2024-12-31) — Capital Stock: 17869000.00
NYT balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 199448000.00
NYT balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 565922000.00
NYT cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -82855000.00
NYT cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -192715000.00
NYT cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -306086000.00
NYT cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 410512000.00
NYT cash_flow (annual, 2024-12-31) — Change In Account Payable: -21031000.00
NYT cash_flow (annual, 2024-12-31) — Change In Other Current Assets: 2403000.00
NYT cash_flow (annual, 2024-12-31) — Change In Other Working Capital: 20234000.00
NYT cash_flow (annual, 2024-12-31) — Change In Payable: -21031000.00
NYT cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -21031000.00
NYT cash_flow (annual, 2024-12-31) — Change In Receivables: -7042000.00
NYT cash_flow (annual, 2024-12-31) — Change In Working Capital: -5436000.00
NYT cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -7042000.00
NYT cash_flow (annual, 2024-12-31) — Changes In Cash: -88289000.00
NYT balance_sheet (annual, 2024-12-31) — Common Stock: 17869000.00
NYT cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: -82855000.00
NYT balance_sheet (annual, 2024-12-31) — Common Stock Equity: 1927209000.00
NYT cash_flow (annual, 2024-12-31) — Common Stock Issuance: 0.00
NYT cash_flow (annual, 2024-12-31) — Common Stock Payments: -85043000.00
NYT balance_sheet (annual, 2024-12-31) — Construction In Progress: 20628000.00
NYT balance_sheet (quarterly, 2024-12-31) — Construction In Progress: 20628000.00
NYT income_statement (annual, 2024-12-31) — Cost Of Revenue: 1309514000.00
NYT balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 302841000.00
NYT balance_sheet (annual, 2024-12-31) — Current Assets: 936322000.00
NYT balance_sheet (annual, 2024-12-31) — Current Liabilities: 613529000.00
NYT balance_sheet (annual, 2024-12-31) — Defined Pension Benefit: 71303000.00
NYT balance_sheet (quarterly, 2024-12-31) — Defined Pension Benefit: 71303000.00
NYT cash_flow (annual, 2024-12-31) — Depreciation: 92024000.00
NYT cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 92024000.00
NYT income_statement (annual, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 82936000.00
NYT cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 92024000.00
NYT income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 82936000.00
NYT income_statement (annual, 2024-12-31) — Diluted Average Shares: 165802000.00
NYT income_statement (annual, 2024-12-31) — Diluted EPS: 1.77
NYT income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 293825000.00
NYT income_statement (annual, 2024-12-31) — EBIT: 384440000.00
NYT income_statement (annual, 2024-12-31) — EBITDA: 476464000.00
NYT cash_flow (annual, 2024-12-31) — Earnings Losses From Equity Investments: 0.00
NYT cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -1026000.00
NYT balance_sheet (annual, 2024-12-31) — Employee Benefits: 214641000.00
NYT cash_flow (annual, 2024-12-31) — End Cash Position: 213857000.00
NYT cash_flow (annual, 2024-12-31) — Financing Cash Flow: -192715000.00
NYT balance_sheet (annual, 2024-12-31) — Foreign Currency Translation Adjustments: -2762000.00
NYT cash_flow (annual, 2024-12-31) — Free Cash Flow: 381339000.00
NYT cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of Business: 0.00
NYT cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: 0.00
NYT income_statement (annual, 2024-12-31) — Gain On Sale Of Business: 0.00
NYT income_statement (annual, 2024-12-31) — Gain On Sale Of Ppe: 0.00
NYT balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -365806000.00
NYT income_statement (annual, 2024-12-31) — General And Administrative Expense: 307930000.00
NYT balance_sheet (annual, 2024-12-31) — Goodwill: 412173000.00
NYT balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 667702000.00
NYT balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 261648000.00
NYT balance_sheet (annual, 2024-12-31) — Gross PPE: 1426643000.00
NYT income_statement (annual, 2024-12-31) — Gross Profit: 1276405000.00
NYT cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 113091000.00
NYT income_statement (annual, 2024-12-31) — Interest Expense: 1017000.00
NYT income_statement (quarterly, 2024-12-31) — Interest Expense: 254000.00
NYT income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 1017000.00
NYT income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 254000.00
NYT income_statement (annual, 2024-12-31) — Interest Income: 37502000.00
NYT income_statement (annual, 2024-12-31) — Interest Income Non Operating: 37502000.00
NYT cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 716000.00
NYT balance_sheet (annual, 2024-12-31) — Invested Capital: 1927209000.00
NYT cash_flow (annual, 2024-12-31) — Investing Cash Flow: -306086000.00
NYT balance_sheet (annual, 2024-12-31) — Investmentin Financial Assets: 345946000.00
NYT balance_sheet (annual, 2024-12-31) — Investments And Advances: 345946000.00
NYT cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 0.00
NYT balance_sheet (annual, 2024-12-31) — Land And Improvements: 106767000.00
NYT balance_sheet (quarterly, 2024-12-31) — Land And Improvements: 106767000.00
NYT balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 37255000.00
NYT balance_sheet (quarterly, 2024-12-31) — Long Term Capital Lease Obligation: 37255000.00
NYT balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 37255000.00
NYT balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 37255000.00
NYT balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 78244000.00
NYT balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 78244000.00
NYT balance_sheet (annual, 2024-12-31) — Minimum Pension Liabilities: -363874000.00
NYT balance_sheet (annual, 2024-12-31) — Minority Interest: 0.00
NYT balance_sheet (quarterly, 2024-12-31) — Minority Interest: 0.00
NYT income_statement (annual, 2024-12-31) — Minority Interests: 0.00
NYT cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 0.00
NYT cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -85043000.00
NYT income_statement (annual, 2024-12-31) — Net Income: 293825000.00
NYT income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 293825000.00
NYT income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 293825000.00
NYT income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 293825000.00
NYT income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 293825000.00
NYT cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 293825000.00
NYT income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 293825000.00
NYT income_statement (annual, 2024-12-31) — Net Interest Income: 36485000.00
NYT cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -289425000.00
NYT income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 36485000.00